BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 7013039)

  • 21. Living-related and unrelated donor kidney transplantation: comparison between ABO-compatible and incompatible grafts.
    Reding R; Squifflet JP; Pirson Y; Jamart J; De Bruyère M; Moriau M; Latinne D; Carlier M; Alexandre GP
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1511-3. PubMed ID: 3274365
    [No Abstract]   [Full Text] [Related]  

  • 22. Graft rejection.
    Hunter PA
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 3)():239-42. PubMed ID: 3895610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-mediated hemolytic anemia following ABO-mismatched organ transplantation: contributory role of HLA matching and polyclonal antilymphocyte globulin.
    Fabrega AJ; DeChristopher J; Sosler SD; Rivas PA; Vasquez EM; Pollak R
    Clin Transplant; 1996 Apr; 10(2):166-9. PubMed ID: 8664512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of acute rejection of renal allografts with antithymocyte globulin or high-dosage prednisone. Influence of recipient DRw6 and DR matching.
    Hoitsma AJ; Van Lier HJ; Reekers P; Koene RA
    Neth J Med; 1985; 28(6):239-42. PubMed ID: 3892324
    [No Abstract]   [Full Text] [Related]  

  • 25. Transplantation across previously incompatible immunological barriers.
    Magee CC
    Transpl Int; 2006 Feb; 19(2):87-97. PubMed ID: 16441356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of histocompatibility matching in high-risk corneal transplantation: a summary of results from the Collaborative Corneal Transplantation Studies.
    Fink N; Stark WJ; Maguire MG; Stulting D; Meyer R; Foulks G; Smith RE; Rapoza P
    Cesk Oftalmol; 1994 Feb; 50(1):3-12. PubMed ID: 8137435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histocompatibility testing in clinical renal transplantation.
    Braun WE
    Urol Clin North Am; 1983 May; 10(2):231-42. PubMed ID: 6222529
    [No Abstract]   [Full Text] [Related]  

  • 29. Preexistent anti-HLA-DR antibodies and kidney graft survival.
    Sirchia G; Mercuriali F; Scalamogna M; Rosso di San Secondo V; Pizzi C; Poli F; Fortis C; Greppi N
    Transplant Proc; 1979 Mar; 11(1):950-3. PubMed ID: 377727
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of donor-recipient lymphocyte crossmatch and ABO status on rejection risk in cardiac transplantation.
    McKenzie FN; Tadros N; Stiller C; Keown P; Sinclair N; Kostuk W
    Transplant Proc; 1987 Aug; 19(4):3439-41. PubMed ID: 3303513
    [No Abstract]   [Full Text] [Related]  

  • 31. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of HLA and ABO antigens on graft rejection and survival.
    Sanfilippo F
    Clin Lab Med; 1991 Sep; 11(3):537-50. PubMed ID: 1934964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HLA-DR as a criterion in the selection of organ recipients].
    Speiser P; Pausch V
    Wien Med Wochenschr; 1986 Feb; 136(4):89-95. PubMed ID: 3458344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperacute rejection from antibody against class II HLA antigens.
    Ghasemian SR; Light JA; Sasaki TA; Barhyte DY
    Clin Transplant; 1998 Dec; 12(6):569-71. PubMed ID: 9850452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of kidney transplantation in relation to HLA-A, B, DR matching and quality of donor organ.
    Lenhard V; Dreikorn K; Röhl L
    Proc Eur Dial Transplant Assoc; 1980; 17():450-6. PubMed ID: 7017689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive postoperative donor-specific crossmatch correlates with B-cell infiltration and poor graft prognosis.
    Greger B; Grossmann T; Gärtner HV; Hopt UT; Lauchart W
    Transplant Proc; 1990 Aug; 22(4):1900-2. PubMed ID: 2389480
    [No Abstract]   [Full Text] [Related]  

  • 38. HLA-DR matching and B-cell crossmatching in renal transplantation.
    Ting A; Williams KA; Morris PJ
    Transplant Proc; 1980 Sep; 12(3):495-501. PubMed ID: 7013181
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of immunological parameters in kidney transplantation.
    Kreisler JM
    Proc Eur Dial Transplant Assoc; 1983; 19():407-23. PubMed ID: 6348742
    [No Abstract]   [Full Text] [Related]  

  • 40. Significance of HLA-DR matching and of B cell crossmatch tests in vitro and in cadaver renal transplantation.
    Albrechtsen D; Arnesen E; Solheim BG; Thorsby E
    Transplant Proc; 1979 Mar; 11(1):743-7. PubMed ID: 156432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.